Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects
Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects
Truist Securities initiated coverage on Integer Holdings Corporation (NYSE:ITGR), noting the company as one of the largest med device outsource manufacturers and a unique SMID MedTech asset.
Truist Securities开始对Integer Holdings Corporation（纽约证券交易所代码：ITGR）进行报道，指出该公司是最大的医疗设备外包制造商之一，也是SMID MedTech的独特资产。
The analyst notes Integer's profitability and leveraged EPS growth prospects (1.5-2x that of revenue), which can sustain a high-teens 2023-2026 EPS CAGR.
分析师指出，Integer的盈利能力和杠杆每股收益增长前景（收入的1.5-2倍），可以维持2023-2026年每股收益的复合年增长率。
Integer has increasing exposure (through the OEM supply chain) to growth segments & emerging product cycles across the MedTech sector, Truist writes.
Truist写道，Integer（通过原始设备制造商供应链）对整个医疗技术领域的增长细分市场和新兴产品周期的敞口越来越大。
Also, a durable inorganic (tuck-in) strategy can add at least 1-2%+ on top of a high-single-digit organic top-line, the analyst adds.
此外，分析师补充说，耐用的无机（隐藏）策略可以在较高的个位数有机收入基础上增加至少1-2％以上。
Related: Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA.
相关信息：医疗器械制造商Integer将从不断扩大的脉冲场消融市场中获益，BofA将获得升级。
Truist initiates with a Buy rating and a price target of $137.
Truist最初的评级为买入，目标股价为137美元。
Integer has an 18 to 20 percent share in its served markets, which total about $9 billion. The trend is toward increased manufacturer outsourcing as the industry seeks to reduce costs and add redundancy.
Integer在其服务市场中占有18％至20％的份额，总额约为90亿美元。随着该行业寻求降低成本和增加冗余，制造商外包的趋势是增加。
Truist notes that the "med device outsourcing sector is ripe for a player like Integer to drive consolidation as it leverages its growing scale within a highly fragmented market."
Truist指出，“像Integer这样的参与者在高度分散的市场中利用其不断增长的规模，在医疗设备外包领域推动整合的时机已经成熟。”
Truist projects Integer to achieve 8-9% organic revenue growth, surpassing its weighted average market growth rate of 4%-6%, driven by the company's strategic shift towards faster-growing markets, increased market share, and advantages of scale in a consolidating med device outsourcing industry.
Truist预计，Integer将实现8-9％的有机收入增长，超过其4％-6％的加权平均市场增长率，这得益于该公司向增长更快的市场的战略转移、市场份额的增加以及在巩固的医疗设备外包行业中的规模优势。
Additionally, with an annual M&A budget of $250-300 million, the analyst expects an additional 200 basis points of growth per year.
此外，由于年度并购预算为2.5亿至3亿美元，分析师预计每年将再增长200个基点。
In April, Integer reported first-quarter adjusted EPS of $1.14, beating the consensus of $1.11. Sales were $414.81 million, up 10% (organic growth of 6%), beating the consensus of $412.83 million.
4月，Integer公布的第一季度调整后每股收益为1.14美元，超过了市场普遍的1.11美元。销售额为4.1481亿美元，增长10％（有机增长6％），超过了预期的4.1283亿美元。
Price Action: ITGR shares are up 4.76% at $117.34 at last check Wednesday.
价格走势：在周三的最后一次检查中，ITGR股价上涨4.76％，至117.34美元。
Now Read: Ryan Cohen's Wealth Soars On GameStop Stock Rally: How Much Is Video Game Retailer CEO Worth?
立即阅读：瑞安·科恩的财富在GameStop股票上涨中飙升：电子游戏零售商首席执行官身价多少？
Photo: Shutterstock
照片：Shutterstock
译文内容由第三方软件翻译。